抑郁症状与疲劳独立关联重症肌无力特异性生活质量而非神经严重度:一项横断面研究
Depressive symptoms and fatigue are independently associated with myasthenia gravis-specific quality of life beyond neurological severity: a cross-sectional study
该横断面登记研究纳入75名成人重症肌无力(MG)患者,结果显示抑郁症状和疲劳独立于神经严重度,与MG特异性生活质量(MG-QOL15)显著相关。研究指出,仅依靠神经严重度评估可能低估患者感知疾病负担,建议在临床稳定期也开展心理与疲劳筛查。
- Article
- Open access
- Published: 16 October 2026
- Viktorija Ķēniņa1,2,3 na1,
- Vladimirs Krutovs1,2,3 na1,
- Ieva Glāzere1,2,3,
- Marija Roddate1,2,3,
- Gundega Ķauķe1,2,
- Roza Renemane4,
- Violeta Žukova1,2 &
- …
- Lubova Renemane5,6
Scientific Reports (2026) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Abstract
Neurological examination and myasthenia gravis (MG)-specific functional scales may not fully capture the psychological and fatigue-related burden of MG. This cross-sectional registry-based study included 75 adults with MG. Depressive and anxiety symptoms were assessed using the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) with validated Latvian- and Russian-language thresholds. Fatigue, quality of life, functional impairment and clinical severity were assessed using the Fatigue Severity Scale (FSS), 15-item Myasthenia Gravis Quality of Life Questionnaire (MG-QOL15), Myasthenia Gravis Activities of Daily Living (MG-ADL) and MG Composite Score (MGCS). Analyses included group comparisons, Spearman correlations, and exploratory multivariable linear regression. Positive depression and anxiety screens were identified in 32/75 (42.7%) and 38/75 (50.7%) patients using language-specific thresholds, compared with 25/75 (33.3%) and 18/75 (24.0%) using conventional thresholds, despite low-to-moderate disease activity (median MGCS 3; MG-ADL 1). Depressive symptoms were associated with poorer MG-QOL15, higher MGCS, greater functional impairment and higher anxiety scores, whereas anxiety correlated only weakly with MG-QOL15 (rho = 0.270). Neurological severity alone may underestimate patient-perceived disease burden. Depressive symptoms and fatigue contribute independently to MG-specific quality of life beyond conventional clinical severity assessment, supporting psychological and fatigue screening even in patients with apparent clinical stability.
Abbreviations
- CI:
-
Confidence interval
- FSS:
-
Fatigue Severity Scale
- GAD-2:
-
Generalized anxiety disorder-2
- GAD-7:
-
Generalized anxiety disorder-7
- GDPR:
-
General data protection regulation
- IQR:
-
Interquartile range
- MG:
-
Myasthenia gravis
- MG-ADL:
-
Myasthenia gravis activities of daily living
- MGCS:
-
Myasthenia gravis composite score
- MGFA:
-
Myasthenia Gravis Foundation of America
- MG-QOL15:
-
15-item Myasthenia Gravis Quality of Life Questionnaire
- PHQ-2:
-
Patient Health Questionnaire-2
- PHQ-9:
-
Patient Health Questionnaire-9
- SD:
-
Standard deviation
- VIF:
-
Variance inflation factor
Funding
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Author information
Author notes
Viktorija Ķēniņa and Vladimirs Krutovs contributed equally to this work.
Authors and Affiliations
Department of Neurology, Pauls Stradiņš Clinical University Hospital, Riga, Latvia
Viktorija Ķēniņa, Vladimirs Krutovs, Ieva Glāzere, Marija Roddate, Gundega Ķauķe & Violeta Žukova
Centre for Rare Neurological Diseases, Pauls Stradiņš Clinical University Hospital, Riga, Latvia
Viktorija Ķēniņa, Vladimirs Krutovs, Ieva Glāzere, Marija Roddate, Gundega Ķauķe & Violeta Žukova
Department of Biology and Microbiology, Faculty of Medicine, Rīga Stradiņš University, Dzirciema iela 16, Riga, 1007, Latvia
Viktorija Ķēniņa, Vladimirs Krutovs, Ieva Glāzere & Marija Roddate
Centre of Neuroimmunology and Imunodeficiencies, Riga, Latvia
Roza Renemane
Department of Psychiatry and Narcology, Rīga Stradiņš University, Riga, Latvia
Lubova Renemane
National Mental Health Centre, Riga, Latvia
Lubova Renemane
Authors
- Viktorija Ķēniņa
- Vladimirs Krutovs
- Ieva Glāzere
- Marija Roddate
- Gundega Ķauķe
- Roza Renemane
- Violeta Žukova
- Lubova Renemane
Corresponding author
Correspondence to Viktorija Ķēniņa.
Ethics declarations
Ethical considerations
The study was approved by the Research Ethics Committee of Rīga Stradiņš University (approval number: 2-PĒK-4/941/2025) and conducted in accordance with the Declaration of Helsinki. All participants provided written informed consent before enrolment. Registry data were pseudonymized using unique patient identifiers and analyzed only in aggregated form to ensure participant confidentiality.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Ķēniņa, V., Krutovs, V., Glāzere, I. et al. Depressive symptoms and fatigue are independently associated with myasthenia gravis-specific quality of life beyond neurological severity: a cross-sectional study. Sci Rep (2026). https://doi.org/10.1038/s41598-026-75399-y
Received: 01 September 2026
Accepted: 06 October 2026
Published: 16 October 2026
DOI: https://doi.org/10.1038/s41598-026-75399-y
Keywords
来源:Nature 健康护理主题 · nature.com